Roivant Sciences LTD DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Roivant Sciences Ltd. has issued its proxy statement for the 2026 Annual General Meeting of Shareholders, detailing proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Roivant Sciences Ltd. has filed a Definitive Additional Materials proxy statement with the SEC.
NASDAQ
Roivant Sciences Ltd. announced its 2025 Annual General Meeting to be held on September 10, 2025, where shareholders will vote on director elections, auditor ratification, and an advisory vote on executive compensation, alongside a review of fiscal year 2024 operational achievements.
NASDAQ
Roivant Sciences Ltd. has filed a definitive proxy statement with the SEC.
NASDAQ
Roivant Sciences Ltd. will hold its 2024 Annual General Meeting of Shareholders on September 10, 2024, to elect directors, ratify the appointment of Ernst & Young LLP, and conduct advisory votes on executive compensation.